» Articles » PMID: 39393252

Cryo-EM Structures of Cardiac Muscle α-actin Mutants M305L and A331P Give Insights into the Structural Mechanisms of Hypertrophic Cardiomyopathy

Overview
Journal Eur J Cell Biol
Publisher Elsevier
Specialty Cell Biology
Date 2024 Oct 11
PMID 39393252
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac muscle α-actin is a key protein of the thin filament in the muscle sarcomere that, together with myosin thick filaments, produce force and contraction important for normal heart function. Missense mutations in cardiac muscle α-actin can cause hypertrophic cardiomyopathy, a complex disorder of the heart characterized by hypercontractility at the molecular scale that leads to diverse clinical phenotypes. While the clinical aspects of hypertrophic cardiomyopathy have been extensively studied, the molecular mechanisms of missense mutations in cardiac muscle α-actin that cause the disease remain largely elusive. Here we used cryo-electron microscopy to reveal the structures of hypertrophic cardiomyopathy-associated actin mutations M305L and A331P in the filamentous state. We show that the mutations have subtle impacts on the overall architecture of the actin filament with mutation-specific changes in the nucleotide binding cleft active site, interprotomer interfaces, and local changes around the mutation site. This suggests that structural changes induced by M305L and A331P have implications for the positioning of the thin filament protein tropomyosin and the interaction with myosin motors. Overall, this study supports a structural model whereby altered interactions between thick and thin filament proteins contribute to disease mechanisms in hypertrophic cardiomyopathy.

Citing Articles

The hypertrophic cardiomyopathy-associated A331P actin variant enhances basal contractile activity and elicits resting muscle dysfunction.

Doran M, Rynkiewicz M, Despond E, Viswanathan M, Madan A, Chitre K iScience. 2025; 28(2):111816.

PMID: 39981516 PMC: 11841076. DOI: 10.1016/j.isci.2025.111816.

References
1.
Debold E, Saber W, Cheema Y, Bookwalter C, Trybus K, Warshaw D . Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro. J Mol Cell Cardiol. 2009; 48(2):286-92. PMC: 2813351. DOI: 10.1016/j.yjmcc.2009.09.014. View

2.
Holmes K, Lehman W . Gestalt-binding of tropomyosin to actin filaments. J Muscle Res Cell Motil. 2009; 29(6-8):213-9. DOI: 10.1007/s10974-008-9157-6. View

3.
Ceron R, Carman P, Rebowski G, Boczkowska M, Heuckeroth R, Dominguez R . A solution to the long-standing problem of actin expression and purification. Proc Natl Acad Sci U S A. 2022; 119(41):e2209150119. PMC: 9565351. DOI: 10.1073/pnas.2209150119. View

4.
Risi C, Schafer L, Belknap B, Pepper I, White H, Schroder G . High-Resolution Cryo-EM Structure of the Cardiac Actomyosin Complex. Structure. 2020; 29(1):50-60.e4. PMC: 7796959. DOI: 10.1016/j.str.2020.09.013. View

5.
Wong W, Doyle T, Cheung P, Olson T, Reisler E . Functional studies of yeast actin mutants corresponding to human cardiomyopathy mutations. J Muscle Res Cell Motil. 2002; 22(8):665-74. DOI: 10.1023/a:1016354308436. View